Sanofi-Aventis' expansion of its already-juicy deal with Regeneron Pharmaceuticals Inc. adds five years to the arrangement and at least $800 million, and may put some observers in mind of the historic partnership between Genentech Inc. and Roche Holdings AG. (BioWorld Today) Read More
